Kazia Therapeutics Ltd (KZIA)
0.295
+0.02
(+8.46%)
USD |
NASDAQ |
May 06, 16:00
0.2902
0.00 (0.00%)
After-Hours: 20:00
Kazia Therapeutics Price to Book Value: 2.167 for May 6, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 06, 2024 | 2.167 |
| May 03, 2024 | 1.998 |
| May 02, 2024 | 2.075 |
| May 01, 2024 | 2.194 |
| April 30, 2024 | 2.459 |
| April 29, 2024 | 2.608 |
| April 26, 2024 | 2.718 |
| April 25, 2024 | 2.718 |
| April 24, 2024 | 2.857 |
| April 23, 2024 | 2.902 |
| April 22, 2024 | 2.769 |
| April 19, 2024 | 2.762 |
| April 18, 2024 | 2.543 |
| April 17, 2024 | 2.528 |
| April 16, 2024 | 2.138 |
| April 15, 2024 | 2.255 |
| April 12, 2024 | 2.615 |
| April 11, 2024 | 2.644 |
| April 10, 2024 | 3.136 |
| April 09, 2024 | 3.372 |
| April 08, 2024 | 2.975 |
| April 05, 2024 | 2.672 |
| April 04, 2024 | 2.448 |
| April 03, 2024 | 2.474 |
| April 02, 2024 | 2.419 |
| Date | Value |
|---|---|
| April 01, 2024 | 2.387 |
| March 28, 2024 | 2.276 |
| March 27, 2024 | 2.304 |
| March 26, 2024 | 2.318 |
| March 25, 2024 | 1.969 |
| March 22, 2024 | 1.983 |
| March 21, 2024 | 1.867 |
| March 20, 2024 | 2.049 |
| March 19, 2024 | 1.872 |
| March 18, 2024 | 1.708 |
| March 15, 2024 | 1.645 |
| March 14, 2024 | 1.641 |
| March 13, 2024 | 1.647 |
| March 12, 2024 | 1.520 |
| March 11, 2024 | 1.479 |
| March 08, 2024 | 1.525 |
| March 07, 2024 | 1.615 |
| March 06, 2024 | 1.586 |
| March 05, 2024 | 1.616 |
| March 04, 2024 | 1.829 |
| March 01, 2024 | 1.887 |
| February 29, 2024 | 1.874 |
| February 28, 2024 | 1.910 |
| February 27, 2024 | 2.049 |
| February 26, 2024 | 2.180 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.4102
Minimum
Dec 28 2022
17.51
Maximum
Nov 18 2020
3.662
Average
3.086
Median
Apr 12 2023
Price to Book Value Benchmarks
| Immutep Ltd | -- |
| Opthea Ltd | -- |
| Alterity Therapeutics Ltd | -- |
| Mesoblast Ltd | -- |
| Immuron Ltd | 1.204 |
Price to Book Value Related Metrics
| PS Ratio | 13622.02 |
| Price | 0.295 |
| Earnings Yield | -124.3% |
| Market Cap | 7.777M |